|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Chlamydia trachomatis Antibodies (IgG, IgA, IgM)
Test Code36581
CPT Codes
86631 (x2), 86632
Preferred Specimen
1 mL serum
Minimum Volume
0.1 mL
Instructions
Serum: Collect in a serum separator tube or red-top tube (no gel). The tube should be centrifuged after clotting. Spun serum separator tubes may be submitted at room temperature or refrigerated unopened without transfer to a plastic screw-cap vial.
Red-top tube (no gel) serum should be transferred to a plastic screw-cap vial and submitted for testing.
Red-top tube (no gel) serum should be transferred to a plastic screw-cap vial and submitted for testing.
Transport Container
Plastic screw-cap vial
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Samples submitted in original red-top tube (no gel) • Gross hemolysis • Grossly lipemic • Grossly icteric
Methodology
Immunofluorescence Assay (IFA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Mon-Sat; Report available: 1-3 days
Reference Range
C. trachomatis Ab (IgG) | <1:64 |
C. trachomatis Ab (IgA) | <1:16 |
C. trachomatis Ab (IgM) | <1:10 |
Clinical Significance
Chlamydia trachomatis is the most common sexually transmitted bacterial infection. Up to 70% of women and 30% of men may be asymptomatic. Infection may lead to tubal pregnancy, pelvic inflammatory disease and infertility. Other organs may also become affected.